داروسازیزهراوی
دزهراوی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,280 2.92
Close Price: 5,280
Cash Flow
AGM
Interim
2026/05/05 Fiscal Year 2026/03/2012 Month | 2026/04/26 Fiscal Year 2026/03/2012 Month / Audited | ||
|---|---|---|---|
Cash Generated from Operations | -216.828 Billion | -216.828 Billion | |
Income Taxes Paid | -371.09 Billion | -371.09 Billion | |
Net Cash Flow from Operating Activities | -587.918 Billion | -587.918 Billion | |
Purchases of Property, Plant and Equipment | -441.5 Billion | -441.5 Billion | |
Purchases of Intangible Assets | -59.145 Billion | -59.145 Billion | |
دریافت های نقدی حاصل از سود تسهیلات اعطایی به دیگران | 102.979 Billion | 102.979 Billion | |
Cash Received from Income on Other Investments | 31.028 Billion | 31.028 Billion | |
Net Cash Flow from Investing Activities | -366.638 Billion | -366.638 Billion | |
Net Cash Flow before Financing Activities | -954.556 Billion | -954.556 Billion | |
Proceeds from Sale of Treasury Shares | 36.08 Billion | 36.08 Billion | |
Purchases of Treasury Shares | -31.7 Billion | -31.7 Billion | |
Cash Received from Borrowings | 5.626 Trillion | 5.626 Trillion | |
Repayments of Borrowings (Principal) | -3.973 Trillion | -3.973 Trillion | |
Interest Paid on Borrowings | -281.986 Billion | -281.986 Billion | |
Dividends Paid | -14.023 Billion | -14.023 Billion | |
Net Cash Flow from Financing Activities | 1.361 Trillion | 1.361 Trillion | |
Net Increase (Decrease) in Cash | 406.791 Billion | 406.791 Billion | |
Cash at Beginning of Period | 230.293 Billion | 230.293 Billion | |
Effect of Exchange Rate Changes | 56.322 Billion | 56.322 Billion | |
Cash at End of Period | 286.615 Billion | 286.615 Billion |